Navigation Links
Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
Date:10/27/2009

DENVER, Oct. 27 /PRNewswire/ -- A Denver ophthalmologist recently became the first in Colorado to implant a special type of lens during cataract surgery, raising the bar for patient care in the state while increasing the quality of life for his patients.

Dr. Paul Cutarelli, director of Cutarelli Vision in Denver and Fort Collins, said he implanted an advanced nanoFLEX lens in October in the eye of a 70-year-old man whose cataracts in his left eye were so bad he couldn't read any more. Manufactured by STAAR Surgical, the revolutionary lens offers better quality of vision at night, filters ultraviolet light and is made of a high-tech material so close to the human lens that it's easily tolerated by the eye, greatly lowering inflammation complications.

His patient was a retiree who didn't want to lose his active lifestyle, one that includes riding his Harley with his girlfriend, Cutarelli said.

"He waited until I got on his insurance plan," Cutarelli said. "He didn't want anyone else to do the cataract surgery and wanted to have good reading vision in that eye."

The procedure in the patient's left eye took about 10 minutes, during which Cutarelli removed the bad lens and replaced it with the implant.

Just a few hours later, the patient called the doctor from home and told him he could read clearly and saw better out of his left eye than his right one.

The news was part of what makes the doctor's work so rewarding. And the special lens has a very high patient satisfaction rate, he said.

"It's fantastic to work with patients like this because I can help them stay active. This is a quality of life issue. Without this lens, this guy wouldn't be able to live the full life that he enjoys."

The procedure is just one of many "firsts" for Cutarelli in Colorado. He also was the first to use the lens in northern Colorado at his Fort Collins practice. That surgery also took place in October. His patient is a Wal-Mart greeter whose vision is now 20/20 and saw vibrant colors for the first time in many years.

He was also the first to use Intacs to fight keratoconus, a disease that causes debilitating astigmatisms and fluctuating vision problems in patients. Intacs are plastic rings implanted under the eye's outer most layer, the cornea, and correct its distorted shape caused by pressure problems associated with the disease.

Cutarelli has also done a great deal of published research, always staying abreast of the newest trends and technologies in vision correction. He was a coinvestigator during more than 15 FDA clinical trials for excimer lasers, the biggest developments in laser vision surgery to appear in the last decade. His work has also appeared in numerous scientific publications reviewed by his peers, including Ophthalmology and Current Eye Research, as well as several book chapters on laser eye surgery.

An expert in correcting refractive and presbyopic problems, Cutarelli has performed more than 60,000 LASIK and LASEK procedures in Colorado. He's one of only a few who've had one-year fellowships in refractive and corneal surgeries, including transplants, and is certified by the American Board of Ophthalmology.

Before he opened his practice in Denver, Cutarelli directed refractive surgery and was an assistant ophthalmology professor at University Hospitals in Cleveland, Ohio. There, he founded the hospitals' refractive surgery fellowship training program. And he taught medical students at his alma mater, Case Western Reserve University.

His expertise has been sought after internationally, at London's Moorfields Eye Hospital and the Al Noor Hospital in the United Arab Emirates.

www.denverlasik.com

www.fortcollinsvision.com

Source: Cutarelli Vision

    CONTACT:
    Cutarelli Vision
    7887 E Belleview Ave
    Denver (Englewood), CO    80111
    (303) 486-2020   

SOURCE Cutarelli Vision


'/>"/>
SOURCE Cutarelli Vision
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Datta ... M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a ... Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
Breaking Medicine News(10 mins):